Skip to content
Abierto
Menu

Combined synopsis and solicitation

BioAnalytical Instruments Reagents and Supplies

75D301-25-Q-78604

Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Medical Laboratories.

View on SAM.govMarkdown

Awarded

Bioanalytical Instruments Inc.

$89,057.00 obligated so far on USAspending

Description

As published on SAM.gov.

This procurement is for the purchase of approved FDA reagents. FDA approved tests performed at the laboratory requre the use of the specific enzymes listed below:

SuperScript TM III Platinum TM CDC Triplex RT-PCR IDV EUA SuperScript TM III Platinum TM CDC DENV-1-4 RT-PCR IDV 510K TaPath TM CDC COVID-19 RT-PCR IDV 510K TaPath TM CDC Influenza RT PCR IDV 510K

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Bioanalytical Instruments Inc.
UEI
W5KQZVDTKVK6
CAGE
30JB1
Vendor location
San Juan, PR
Contract
75D30125P20459, purchase order
Obligated
$89,057.00
Actions
1 between May 21, 2025 and May 21, 2025
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Laboratory Reagents
Match
solicitation number 75D30125Q78604 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 9, 2025

    Combined synopsis and solicitation

    Due May 13, 2025 at 4:00 PM EDT. SAM.gov, notice 91c0401b9eaf46258a2dd7b9e740bd21

  2. May 9, 2025

    Combined synopsis and solicitation

    Due May 13, 2025 at 4:00 PM EDT. SAM.gov, notice e503453ce38347e7955977b1deae7f59

Points of contact

Also open from this buyer